| Title : Reasons that prevent the inclusion of Alzheimer's disease patients in clinical trials - Rollin-Sillaire_2013_Br.J.Clin.Pharmacol_75_1089 |
| Author(s) : Rollin-Sillaire A , Breuilh L , Salleron J , Bombois S , Cassagnaud P , Deramecourt V , Mackowiak MA , Pasquier F |
| Ref : British Journal of Clinical Pharmacology , 75 :1089 , 2013 |
| Abstract : Rollin-Sillaire_2013_Br.J.Clin.Pharmacol_75_1089 |
| ESTHER : Rollin-Sillaire_2013_Br.J.Clin.Pharmacol_75_1089 |
| PubMedSearch : Rollin-Sillaire_2013_Br.J.Clin.Pharmacol_75_1089 |
| PubMedID: 22891847 |
Rollin-Sillaire A, Breuilh L, Salleron J, Bombois S, Cassagnaud P, Deramecourt V, Mackowiak MA, Pasquier F (2013)
Reasons that prevent the inclusion of Alzheimer's disease patients in clinical trials
British Journal of Clinical Pharmacology
75 :1089
Rollin-Sillaire A, Breuilh L, Salleron J, Bombois S, Cassagnaud P, Deramecourt V, Mackowiak MA, Pasquier F (2013)
British Journal of Clinical Pharmacology
75 :1089